1. Metastatic Bladder Cancer
   J.L. Chin et al, 2017, Introduction to Cancer Metastasis CrossRef
2. FGFR3 – a Central Player in Bladder Cancer Pathogenesis?
   Margaret A. Knowles, 2020, Bladder Cancer CrossRef
3. Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples
   Masahiro Kurobe et al, 2016, PLOS ONE CrossRef
4. Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma
   Mehdi Kardoust Parizi et al, 2021, Urologic Oncology: Seminars and Original Investigations CrossRef
5. Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
   Constance Le Goux et al, 2020, Scientific Reports CrossRef
6. Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study
   Uwe Bieri et al, 2022, Frontiers in Oncology CrossRef
7. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer
   Katarzyna Starska et al, 2018, Cellular Oncology CrossRef
8. Investigation of the mutational status of the FGFR3 gene in urothelial bladder carcinoma
   E.M. Oliushina et al, 2023, Arkhiv patologii CrossRef
9. Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis
   Sidra Khalid et al, 2020, European Urology Open Science CrossRef
10. Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs
    Stefan Harsanyi et al, 2022, International Journal of Molecular Sciences CrossRef